PATHOGENESIS OF AIDS



Similar documents
Viral Replication. Viral Replication: Basic Concepts

Viral Infection: Receptors

TOWARDS AN HIV VACCINE

Chapter 43: The Immune System

Viruses. Viral components: Capsid. Chapter 10: Viruses. Viral components: Nucleic Acid. Viral components: Envelope

The Immune System: A Tutorial

specific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins

What is HIV? What is AIDS? The HIV pandemic HIV transmission Window period Stages of HIV infection

B cell activation and Humoral Immunity

Pathophysiology of the human immunodeficiency virus

HIV or AIDS. What is HIV? 2 HIV & AIDS

Chapter 21. What Are HIV and AIDS?

2) Macrophages function to engulf and present antigen to other immune cells.

I d like to thank the organizers for this chance to talk to you about our data and for putting together this exciting workshop.

B Cells and Antibodies

Gene Therapy. The use of DNA as a drug. Edited by Gavin Brooks. BPharm, PhD, MRPharmS (PP) Pharmaceutical Press

The immune system and HIV

10. T and B cells are types of a. endocrine cells. c. lymphocytes. b. platelets. d. complement cells.

LYMPHOMA. BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons

LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials

Special report. Chronic Lymphocytic Leukemia (CLL) Genomic Biology 3020 April 20, 2006

Understanding West Nile Virus Infection

Immunity. Humans have three types of immunity innate, adaptive, and passive: Innate Immunity

FAQs HIV & AIDS. What is HIV? A virus that reduces the effectiveness of your immune system, meaning you are less protected against disease.

Chapter 36. Media Directory. Characteristics of Viruses. Primitive Structure of Viruses. Therapy for Viral Infections. Drugs for Viral Infections

Activation and effector functions of HMI

Microbiology AN INTRODUCTION EIGHTH EDITION

Name (print) Name (signature) Period. (Total 30 points)

ELISA BIO 110 Lab 1. Immunity and Disease

Comparative Drug Ranking for Clinical Decision Support in HIV Treatment

Human CD4+T Cell Care Manual

Malignant Lymphomas and Plasma Cell Myeloma

Mathematical Analysis of HIV-1 Dynamics in Vivo

The Body s Defenses CHAPTER 24

The Immune System. 2 Types of Defense Mechanisms. Lines of Defense. Line of Defense. Lines of Defense

One of the more complex systems we re looking at. An immune response (a response to a pathogen) can be of two types:

Quick Hit Activity Using UIL Science Contests For Formative and Summative Assessments of Pre-AP and AP Biology Students

The immune system. Bone marrow. Thymus. Spleen. Bone marrow. NK cell. B-cell. T-cell. Basophil Neutrophil. Eosinophil. Myeloid progenitor

bitter is de pil Linos Vandekerckhove, MD, PhD

Dendritic Cells: A Basic Review *last updated May 2003

Immunity Unit Test Z

Aktuell HIV-forskning

Various Viral Vectors Necessary for Gene Therapy Delivery Systems. Abstract

What actually is the immune system? What is it made up of?

T Cell Maturation,Activation and Differentiation

Course Descriptions. I. Professional Courses: MSEG 7216: Introduction to Infectious Diseases (Medical Students)

Immunology Ambassador Guide (updated 2014)

Pediatric HIV - The World At It's Best

Pulling the Plug on Cancer Cell Communication. Stephen M. Ansell, MD, PhD Mayo Clinic

Final Review. Aptamers. Making Aptamers: SELEX 6/3/2011. sirna and mirna. Central Dogma. RNAi: A translation regulation mechanism.

Immunodeficiency. Introduction

Epstein Barr Virus (EBV) Serological Diagnosis of Epstein Barr Virus. Epstein Barr Virus (EBV) Epstein Barr Virus (EBV)

PATHOLOGY OF AIDS. Edward C. Klatt, MD. Version 26. Copyright by Edward C. Klatt, MD All rights reserved worldwide

HemaCare Corporation Company Overview. Comprehensive Product and Service Solutions for BioResearch and Cellular Therapy

How Does a Doctor Test for AIDS?

Cytotoxic T Lymphocytes (CTLs) and NK Cells. Effector T cells. After activation, naïve T cells differentiate into effector and memory T cells

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON DEVELOPMENT AND MANUFACTURE OF LENTIVIRAL VECTORS

Blood, Lymphatic and Immune Systems

Autoimmunity and immunemediated. FOCiS. Lecture outline

HIV and Autoimmune Disease - The Cure Research

The Polio Virus. Getting to Know Your Old Enemy. Marcia Falconer, Ph.D.

Compartmentalization of the Cell. Objectives. Recommended Reading. Professor Alfred Cuschieri. Department of Anatomy University of Malta

The Nucleus: DNA, Chromatin And Chromosomes

HUMORAL IMMUNE RE- SPONSES: ACTIVATION OF B CELLS AND ANTIBODIES JASON CYSTER SECTION 13

Viral load testing. medical monitoring: viral load testing: 1

Immunomodulatory properties. of the HIV-1 Tat protein. Francesco Nicoli

Enter this essay in the English Language Learner (for 5 years or less of English) category: _X_ Yes

INTERPRETATION INFORMATION SHEET

Combination Anti-Retroviral Therapy (CART) - Rationale and Recommendation. M Dinaker. Fig.1: Effect of CART on CD4 and viral load

2.1.2 Characterization of antiviral effect of cytokine expression on HBV replication in transduced mouse hepatocytes line

BioResearch. Hematopoietic and Immune Cell Products Essential Tools for Hematopoietic Research

How do plasma cells survive

Bacteria vs. Virus: What s the Difference? Grade 11-12

The State Hospital HIV / AIDS

Problem Set 6 KEY

COMMUNICABLE DISEASE

TABLE OF CONTENTS INTRODUCTION MODULE HIV Case Definition and the Human Immune System. MODULE HIV Case Report Forms

TG1050, A NOVEL IMMUNOTHERAPEUTIC TO TREAT CHRONIC HEPATITIS B, CAN CONTROL HBsAg AND PROVOKE HBsAg SEROCONVERSION IN HBV-PERSISTENT MOUSE MODELS

SYMPOSIUM. June 15, Photonics Center Colloquium Room (906) 8 Saint Mary's St., Boston, MA Boston University

Up to $402,000. Insight HIV. Drug Class. 1.2 million people in the United States were living with HIV at the end of 2011 (most recent data).

An overview of CLL care and treatment. Dr Dean Smith Haematology Consultant City Hospital Nottingham

Mature Lymphoproliferative disorders (2): Mature B-cell Neoplasms. Dr. Douaa Mohammed Sayed

Uses of Flow Cytometry

Hepatitis C Monitoring and Complications (and Treatment!) Dr Mark Douglas

BLOOD-Chp. Chp.. 6 What are the functions of blood? What is the composition of blood? 3 major types of plasma proteins

Epstein-Barr virus-associated lymphoproliferative disease following allogeneic stem cell transplantation

7- Master s Degree in Public Health and Public Health Sciences (Majoring Microbiology)

Transcription:

Neal Nathanson, MD Emeritus Professor Department of Microbiology University of Pennsylvania School of Medicine 1

Definitions Structure of HIV HIV entry and cell tropism HIV-cell interactions Course of HIV infection and AIDS HIV variants during infection HIV persistence How does HIV cause immunodeficiency? 2

DEFINITIONS HIV: human immunodeficiency virus HIV is a member of the lentivirus family, a subgroup of retroviruses, RNA viruses that replicate via a DNA intermediate AIDS: acquired immunodeficiency syndrome AIDS is defined by a loss of CD4 T lymphocytes or the occurrence of opportunistic infections or cancers 3

STRUCTURE OF HIV 4

A diagram of the virus particle to show the internal structure (after Brooks et al, 1998) VIRUS SPIKE CONSISTING OF TWO ENVELOPE PROTEINS gp120 and gp 41 VIRUS ENVELOPE (LIPID BILAYER) VIRUS CAPSID CONTAINING THE RNA GENOME 5

The genes of HIV in the virion (RNA) and integrated into host cell genome (DNA) AUXILIARY GENES STRUCTURAL GENES 6

HIV ENTRY INTO CELLS AND CELL TROPISM 7

HIV attaches to cells in two steps STEP 1 HIV attaches to its primary receptor, CD4 STEP 2 HIV attaches to a co-receptor, either CCR5 or CXCR4 STEP 1 STEP 2 8

HIV infects cells that carry the receptor and co-receptor CD4 Expressed on the surface of CD4 T lymphocytes (helper T lymphocytes) and macrophages (including dendritic cells) CCR5 CXCR4 Expressed on CD4+ T lymphocytes and on macrophages Expressed on CD4+ T lymphocytes and T cell lines R5 VIRUSES X4 VIRUSES 9

HIV-CELL INTERACTIONS 10

HIV infection of cultured cells shows (Collman, 1989) both R5 and X4 viruses infect and kill CD4 T lymphocytes p24 ANTIGEN (LOG NG/ML) 3 2 1 0-1 -2 PERIPHERAL BLOOD LYMPHOCYTES INFECTED CELLS DIE MACROPHAGE-TROPIC VIRUS (SF162) TCL-ADAPTED VIRUS (IIIB) 0 10 20 30 MONOCYTE-DERIVED MACROPHAGES 3 2 Only R5 viruses infect macrophages and they are not killed 1 0-1 INFECTED CELLS SURVIVE -2 NEGATIVE 0 10 20 30 11

COURSE OF HIV INFECTION AND AIDS 12

HOW HIV INITIATES HETEROSEXUAL INFECTION (Shattock, 2003) 13

THE COURSE OF HIV INFECTION AND AIDS (After Fauci, 1993) PRIMARY INFECTION CLINICAL LATENCY AIDS OPPORTUNISTIC INFECTIONS HIV RNA (LOG 10 COPIES PER ML) 7 6 5 4 3 2 1 0 HIV RNA CD4 COUNT 0 0.06 0.12 0.18 0.23 1 2 4 6 8 10 1200 1000 800 600 400 200 0 CD4 T CELLS PER µl YEARS AFTER INFECTION 14

HIV VIREMIA BY STAGE OF HIV INFECTION (Bagasra, 1993; Pan, 1993) STAGE OF INFECTION CD4 CELL COUNT PLASMA HIV (TCID PER ML) % CD4+ CELLS INFECTED ASYMPTOMATIC >500 100 3% GENERAL LYMPHADENOPATHY 300-499 200-299 200 400 20% CLINICAL AIDS <200 1,500 30% 15

HIV VARIANTS DURING INFECTION 16

VIRUS VARIATION IS OFTEN SEEN DURING THE COURSE OF HIV INFECTION BIOLOGICAL PHENOTYPE VIRUS ISOLATED FROM PATIENTS WITH ASYMPTOMATIC EARLY INFECTION AIDS REPLICATION KINETICS SLOW/LOW HIGH/RAPID SYNCYTIUM INDUCTION NON SI SI CELLULAR HOST RANGE DUO-TROPIC T CELL-TROPIC CO-RECEPTOR USAGE R5 X4 17

DIFFERENTIAL INFECTION OF MONKEYS BY CO-RECEPTOR USAGE (Harouse, 1999) MACROPHAGE-TROPIC SHIV SF162P LPL DEPLETED MACROPHAGE-TROPIC (R5) SHIV INFECTS GUT-ASSOCIATED LYMPHOID TISSUE PREFERENTIALLY WITH MODEST REDUCTION OF CD4 CELLS IN CIRCULATION VIREMIA (RNA COPIES PER ML) 7 6 5 4 3 LYMPHOCYTE-TROPIC SHIV SF33A LN DEPLETED 0 6 12 18 24 30 36 42 48 7 6 5 4 3 T CELL-TROPIC (X5) SHIV INFECTS LYMPH NODES PREFERENTIALLY WITH SEVERE REDUCTION OF CIRCULATING CD4 CELLS CD4:CD8 RATIO 2.0 1.5 1.0 0.5 0.0 2.0 1.5 1.0 0.5 0.0 0 6 12 18 24 30 36 42 48 WEEKS AFTER INFECTION 18

HIV PERSISTENCE 19

HIV INFECTION IN VIVO INCLUDES (Ho, 1999) Replication in activated T lymphocytes (1) Replication in macrophages (2) Latency in resting lymphocytes (3) 1 2 3 20

ANTI-RETROVIRAL TREATMENT REFLECTS THE THREE HIV IN VIVO INFECTION CYCLES (Mittler, 1999; and others) 0 DECREASE IN VIREMIA LOG10 HIV RNA -1-2 -3 INFECTED T LYMPHOCYTES (1) t 1/2 ~1 days sensitivity INFECTED MACROPHAGES (2) t 1/2 ~ 14 days LATENTLY INFECTED T CELLS (3) 0 20 40 60 80 DAYS AFTER BEGINNING HAART 21

HOW DOES HIV CAUSE IMMUNODEFICIENCY? 22

CD4 AND CD8 T LYMPHOCYTES: A CENTRAL PARADOX IN THE PATHOGENESIS OF AIDS Opportunistic infections are mainly due to the activation of existing latent infections Control of latent infections is mediated by parasite-specific CD8 effector T lymphocytes, which are NOT the direct target of HIV Indirect mechanisms must be responsible for the depletion of effector CD8 cells, including Hyperactivation of T cells leading to apoptosis and premature cell death 23

Still an enigma? from THE SCIENTIST, 2003 24

25